Most people, study after study shows, don’t take the medicines prescribed for them. It doesn’t matter what they are — statins, high blood pressure drugs, drugs to lower blood sugar, asthma drugs. Either patients never start taking them, or they stop. It’s a problem that doctors call nonadherence — the common human tendency to resist…
Most people, study after study shows, don’t take the medicines prescribed for them. It doesn’t matter what they are — statins, high blood pressure drugs, drugs to lower blood sugar, asthma drugs. Either patients never start taking them, or they stop. It’s a problem that doctors call nonadherence — the common human tendency to resist…
Oprah Winfrey, una figura presente desde hace mucho tiempo en el debate nacional sobre las dietas y los prejuicios sobre el peso, dedicó el lunes un especial de una hora en horario estelar al auge de los medicamentos para adelgazar. Su objetivo, dijo, era “empezar a liberar el estigma, la vergüenza y el juicio” en…
Oprah Winfrey, a longtime figure in the national conversation about dieting and weight bias, devoted an hourlong prime-time special on Monday to the rise of weight loss drugs. Her goal, she said, was to “start releasing the stigma and the shame and the judgment” around weight and weight loss — starting with her own, she…
As drugs like Ozempic become increasingly popular for weight loss, more doctors and patients are looking for ways to counteract the muscle loss that can happen on these medications — and companies are racing to meet that demand. Luxury gyms are offering strength-training programs specifically marketed toward people taking these medications, promising to help clients…
One day about 60 years ago, the comedian Bert Lahr put on a devil suit, held up a potato chip and uttered a phrase that would become a food-marketing milestone: “Betcha can’t eat just one.” Positioning food as deliciously addictive, as Lay’s did in its sly TV commercial, became advertising gold. In the decades that…
